Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Nyse  >  Quest Diagnostics    DGX

QUEST DIAGNOSTICS

(DGX)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
News SummaryMost relevantAll newsPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies

Quest sees Q2 revenue above estimates on demand for COVID-19 testing services

share with twitter share with LinkedIn share with facebook
07/13/2020 | 07:15am EDT

July 13 (Reuters) - Quest Diagnostics reported preliminary second-quarter revenue above analysts' estimates on Monday, largely due to growing demand for its COVID-19 testing services.

The company said revenue fell 6% to about $1.83 billion, but was still ahead of the average analyst estimate of $1.52 billion, according to Refinitiv I/B/E/S data.(https://reut.rs/2Zn5ieJ)

Quest said results also reflect stronger-than-expected recovery in base testing volumes, excluding COVID-19 molecular and antibody testing. (Reporting by Trisha Roy in Bengaluru; Editing by Anil D'Silva)

share with twitter share with LinkedIn share with facebook
Latest news on QUEST DIAGNOSTICS
04:06pQUEST DIAGNOSTICS : Completes Acquisition of Mid America Clinical Laboratories, ..
PR
08:31aQUEST DIAGNOSTICS : Launches Automated Next Generation Sequencing (NGS) Engine T..
PR
07/29QUEST DIAGNOSTICS : Media Statement about COVID-19 Testing
PU
07/29QUEST DIAGNOSTICS : FDA Authorizes New Quest Diagnostics Lab Method Designed to ..
PR
07/27QUEST DIAGNOSTICS : Media Statement about COVID-19 Testing
PU
07/24QUEST DIAGNOSTICS : Management's Discussion and Analysis of Financial Condition ..
AQ
07/23Quest medical lab sees COVID-19 test speed at 'acceptable' level by Sept
RE
07/23No Bars, No Problem for Boston Beer -- Earnings at a Glance
DJ
07/23Drop in Demand Hits Car Makers -- Earnings at a Glance
DJ
07/23QUEST DIAGNOSTICS : 2Q Earnings Snapshot
AQ
More news
Financials (USD)
Sales 2020 8 686 M - -
Net income 2020 1 032 M - -
Net Debt 2020 3 529 M - -
P/E ratio 2020 17,2x
Yield 2020 1,70%
Capitalization 17 461 M 17 461 M -
EV / Sales 2020 2,42x
EV / Sales 2021 2,39x
Nbr of Employees 47 000
Free-Float 61,5%
Chart QUEST DIAGNOSTICS
Duration : Period :
Quest Diagnostics Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends QUEST DIAGNOSTICS
Short TermMid-TermLong Term
TrendsBullishBullishBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 19
Average target price 137,65 $
Last Close Price 130,01 $
Spread / Highest target 19,2%
Spread / Average Target 5,87%
Spread / Lowest Target -7,70%
EPS Revisions
Managers
NameTitle
Stephen H. Rusckowski Chairman, President & Chief Executive Officer
Mark J. Guinan Chief Financial Officer & Executive Vice President
Jay G. Wohlgemuth Chief Medical Officer, Senior VP-R&D, Medical
Gabrielle Wolfson SVP, Chief Information & Digital Officer
Gail R. Wilensky Independent Director
Sector and Competitors